Apr 16, 2026 01:00AM
Apr 16, 2026 01:00AM
Apr 15, 2026 01:00AM
Mar 16, 2026 02:00AM
Mar 16, 2026 02:00AM
Mar 4, 2026 01:00AM
Mar 4, 2026 01:00AM BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy
Nov 19, 2025 03:41PM
Nov 19, 2025 03:41PM
Nov 10, 2025 01:00AM
Jun 3, 2025 06:54PM
May 29, 2025 08:40PM
Dec 17, 2024 07:00AM
Nov 5, 2024 05:00AM BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
Sep 17, 2024 10:51AM
Apr 30, 2024 08:00AM
Apr 18, 2024 04:30PM
Mar 8, 2024 04:04AM
Mar 6, 2024 04:40PM
Feb 21, 2024 01:54PM
Feb 12, 2024 02:17PM BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.
Dec 22, 2023 09:21AM
Dec 22, 2023 09:21AM
Dec 13, 2023 08:00AM
Mar 16, 2023 08:00AM

1,158,058 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All